Literature DB >> 7638015

Pertussis caused by an erythromycin-resistant strain of Bordetella pertussis.

K Lewis1, M A Saubolle, F C Tenover, M F Rudinsky, S D Barbour, J D Cherry.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 7638015     DOI： 10.1097/00006454-199505000-00010

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN： 0891-3668            Impact factor:   2.129


× No keyword cloud information.
  18 in total

1.  Antimicrobial susceptibility testing of clinical isolates of Bordetella pertussis from northern California: report from the SENTRY Antimicrobial Surveillance Program.

Authors:  K A Gordon; J Fusco; D J Biedenbach; M A Pfaller; R N Jones
Journal:  Antimicrob Agents Chemother       Date:  2001-12       Impact factor: 5.191

2.  Reproducibility of Bordetella pertussis genomic DNA fragments generated by XbaI restriction and resolved by pulsed-field gel electrophoresis.

Authors:  Terri H Hardwick; Brian Plikaytis; Pamela K Cassiday; Gary Cage; Mark S Peppler; Deborah Shea; David Boxrud; Gary N Sanden
Journal:  J Clin Microbiol       Date:  2002-03       Impact factor: 5.948

3.  Antimicrobial susceptibility testing of historical and recent clinical isolates of Bordetella pertussis in the United Kingdom using the Etest method.

Authors:  N K Fry; J Duncan; L Vaghji; R C George; T G Harrison
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2010-06-03       Impact factor: 3.267

4.  Emergence of quinolone-resistant Bordetella pertussis in Japan.

Authors:  Masayuki Ohtsuka; Ken Kikuchi; Kenichiro Shimizu; Namiko Takahashi; Yuka Ono; Takashi Sasaki; Keiichi Hiramatsu
Journal:  Antimicrob Agents Chemother       Date:  2009-05-04       Impact factor: 5.191

Review 5.  State of art in antibacterial susceptibility of Bordetella pertussis and antibiotic treatment of pertussis.

Authors:  J E Hoppe
Journal:  Infection       Date:  1998 Jul-Aug       Impact factor: 3.553

6.  Update of epidemiology, diagnosis, and treatment of pertussis.

Authors:  J E Hoppe
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1996-03       Impact factor: 3.267

Review 7.  Rational prescribing of antibacterials in ambulatory children.

Authors:  J E Hoppe
Journal:  Pharmacoeconomics       Date:  1996-12       Impact factor: 4.981

8.  Identification of a mutation associated with erythromycin resistance in Bordetella pertussis: implications for surveillance of antimicrobial resistance.

Authors:  J M Bartkus; B A Juni; K Ehresmann; C A Miller; G N Sanden; P K Cassiday; M Saubolle; B Lee; J Long; A R Harrison; J M Besser
Journal:  J Clin Microbiol       Date:  2003-03       Impact factor: 5.948

Review 9.  Molecular pathogenesis, epidemiology, and clinical manifestations of respiratory infections due to Bordetella pertussis and other Bordetella subspecies.

Authors:  Seema Mattoo; James D Cherry
Journal:  Clin Microbiol Rev       Date:  2005-04       Impact factor: 26.132

10.  Bordetella pertussis isolates with a heterogeneous phenotype for erythromycin resistance.

Authors:  K E Wilson; P K Cassiday; T Popovic; G N Sanden
Journal:  J Clin Microbiol       Date:  2002-08       Impact factor: 5.948
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.